109 related articles for article (PubMed ID: 27251150)
1. Specialists attack drug agency's fast track approval scheme.
Hawkes N
BMJ; 2016 Jun; 353():i3060. PubMed ID: 27251150
[No Abstract] [Full Text] [Related]
2. Drug approval and research assessment: arguments for reform.
Abbasi K
J R Soc Med; 2016 Sep; 109(9):323. PubMed ID: 27534705
[No Abstract] [Full Text] [Related]
3. Commentary on the European Medicines Agency's extended mandate: Protecting public health in times of crisis and improving availability of medicines and medical devices.
Abed I; Gonzalez-Quevedo R; Mura M; Dias M; da Rocha Dias S; García Burgos J
Br J Clin Pharmacol; 2023 Jan; 89(1):5-10. PubMed ID: 36345231
[No Abstract] [Full Text] [Related]
4. Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy.
Cerreta F; Eichler HG; Rasi G
N Engl J Med; 2012 Nov; 367(21):1972-4. PubMed ID: 23171092
[No Abstract] [Full Text] [Related]
5. CardioPulse: The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors.
Blind E; de Graeff PA; Meurs I; Holtkamp F; Baczynska A; Janssen H
Eur Heart J; 2016 Feb; 37(6):502-3. PubMed ID: 26853264
[No Abstract] [Full Text] [Related]
6. [The Medical Product Agency's work and economics--a comment].
Ahlqvist Rastad J; Salmonson T
Lakartidningen; 2003 Jan; 100(5):345. PubMed ID: 12607382
[No Abstract] [Full Text] [Related]
7. After Avandia, some seek split in drug approval and monitoring.
Dolgin E
Nat Med; 2010 Aug; 16(8):831. PubMed ID: 20689527
[No Abstract] [Full Text] [Related]
8. Muscular dystrophy drug looks set for commercial success despite clinical doubts.
Dyer O
BMJ; 2016 Oct; 355():i5346. PubMed ID: 27698204
[No Abstract] [Full Text] [Related]
9. GlaxoSmithKline is fined record $3bn in US.
Roehr B
BMJ; 2012 Jul; 345():e4568. PubMed ID: 22761252
[No Abstract] [Full Text] [Related]
10. Politics and power plays behind the HPV vaccine. An effective vaccine is mired in controversy by mandates.
Nelson R
Am J Nurs; 2007 Aug; 107(8):23-4. PubMed ID: 17667381
[No Abstract] [Full Text] [Related]
11. German body calls for pause in European plan for fast track drug approval.
Hawkes N
BMJ; 2016 Aug; 354():i4479. PubMed ID: 27530526
[No Abstract] [Full Text] [Related]
12. The European Medicines Agency's goals for regulatory science to 2025.
Hines PA; Guy RH; Humphreys AJ; Papaluca-Amati M
Nat Rev Drug Discov; 2019 Jun; 18(6):403-404. PubMed ID: 31160761
[No Abstract] [Full Text] [Related]
13. College leader in wide-ranging attack on government policies.
Merrifield N
Nurs Times; 2016 Jun 29-Jul 5; 112(26):5. PubMed ID: 27544950
[No Abstract] [Full Text] [Related]
14. Adjustment of Europe's drug regulation to public-health needs.
Thirstrup S; Kampmann JP
Lancet; 2001 Nov; 358(9294):1734. PubMed ID: 11728590
[No Abstract] [Full Text] [Related]
15. Adjustment of Europe's drug regulation to public- health needs.
Wolff F
Lancet; 2001 Nov; 358(9294):1733-4. PubMed ID: 11728586
[No Abstract] [Full Text] [Related]
16. The impact of the Medicines Control Council backlog and fast-track review system on access to innovative and new generic and biosimilar medicines of public health importance in South Africa.
Leng HM; Pollock AM; Sanders D
S Afr Med J; 2016 Mar; 106(4):43-6. PubMed ID: 27032846
[TBL] [Abstract][Full Text] [Related]
17. A note on breast cancer trials with pCR-based accelerated approval.
Xia Y; Cui L; Yang B
J Biopharm Stat; 2014; 24(5):1102-14. PubMed ID: 24926729
[TBL] [Abstract][Full Text] [Related]
18. The European Medicines Agency's plans for sharing data from clinical trials.
Groves T; Godlee F
BMJ; 2013 May; 346():f2961. PubMed ID: 23657192
[No Abstract] [Full Text] [Related]
19. Stimulating the need for healthy critique in occupational therapy.
Pereira RB
Aust Occup Ther J; 2011 Jun; 58(3):220. PubMed ID: 21599689
[No Abstract] [Full Text] [Related]
20. Margaret McCartney: Evidence based protest for the NHS.
McCartney M
BMJ; 2016 Sep; 354():i4745. PubMed ID: 27585705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
